Cardiovascular Systems to distribute Invatec balloon catheter

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Invatec, a provider of interventional products, has entered into a distribution agreement with interventional vascular disease treatment system developer Cardiovascular Systems, which recently merged with the biotech firm Replidyne.

Under the terms of the agreement, the St. Paul, Minn.-based CSI will distribute Invatec's recently FDA-cleared percutaneous transluminal angioplasty (PTA) balloon catheter product line, according to the Bethlehem, Pa.-based Invatec. The CSI and Invatec sales forces will partner in selling the Amphirion Deep 0.014 inch PTA balloon catheter line, a below the knee PTA catheter, as well as the Submarine Plus 0.018-inch PTA balloon catheter and the Admiral Xtreme 0.035-inch PTA balloon catheter lines.

Invatec said it will continue to sell and market its other interventional products, such as its thrombus management cathether, the Diver CE and the FiberNet Embolic Protection system.